Specificity and total positive rate of head-up tilt testing potentiated with sublingual nitroglycerin in older patients with unexplained syncope

Aging Clinical and Experimental Research

Volumn 13, Issue 2, 2001, Pages 105-111

  Mussi, C ^a   Tolve, I ^a   Foroni, M ^a   Valli, A ^a   Ascari, S ^a   Salvioli, G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Elderly; Head up tilt testing (HUTT); Nitroglycerin; Syncope

Indexed keywords

GLYCERYL TRINITRATE;

AGE; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENDER; HEAD TILTING; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; REPRODUCIBILITY; SYNCOPE;

EID: 0034992381     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03351532     Document Type: Article

References (30)

1. Syncope in an elderly, institutionalized population: Prevalence, incidence and associated risk
2. Evaluation and outcome of patients with syncope
3. Diagnostic evaluation of syncope
4. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope
5. Head-up tilt: A useful test for investigating unexplained syncope
6. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study
7. Nitroglycerin infusion during upright tilt: A new test for the diagnosis of vasovagal syncope
8. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope
9. Use of sublingual nitroglycerin during head up tilt-table testing in patients older than 60 years of age
10. Cardiac asystole: A manifestation of neurally-mediated hypotension-bradycardia
11. Proposed classification for tilt-induced vasovagal syncope
12. Head-up tilt testing potentiated with low dose sublingual isosorbide dinitrate: A simplified time-saving approach for the evaluation of unexplained syncope
13. Upright tilt testing in evaluating syncope: A comprehensive literature review
14. Evaluation and outcome of emergency room patients with transient loss of consciousness
15. Syncope in the elderly patient
16. Epidemiologic features of isolated syncope: The Framingham Study
17. Evaluation of syncope in the elderly
18. The cost of recurrent syncope of unknown origin in elderly patients
19. Impaired heart rate responses to cough and deep breathing in elderly patients with unexplained syncope
20. Tilting towards a diagnosis in recurrellette P. Significant complications can occur with ischemic heart disease and tilt table testing
21. Nitrates in the Elderly. Pharmacological considerations
22. Dysautonomic syncope
23. A "dysautonomic" head-up tilt test pattern in elderly patients with neurocardiogenic syncope
24. Comparing two different protocols for tilt table testing: Sublingual glyceryl trinitrate versus isoprenaline infusion
25. Evaluation of syncope by upright tilt testing with isoproterenol: A non specific test
26. Clinical pharmacokinetics of nitrates
27. Significant complications can occur with ischemic heart disease and tilt table testing
28. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope
29. Work-up and management of patients with syncope
30. Pharmacologic approaches to therapy for vasovagal syncope